---
title: NSAIDs (INICET High Yield)
markmap:
  colorFreezeLevel: 6
---

## NSAIDs

### Mechanism of Action
- COX Inhibition
  - COX-1: Constitutive (Physiologic functions)
  - COX-2: Inducible (Inflammation, Pain, Fever)
- Effects
  - Anti-inflammatory
  - Analgesic
  - Antipyretic
  - Antiplatelet (Aspirin irreversible)

### Classification
- Non-selective COX Inhibitors (ns-NSAIDs)
  - Salicylates (Aspirin, Diflunisal)
  - Propionic Acid Deriv (Ibuprofen, Naproxen, Ketoprofen, Flurbiprofen)
  - Acetic Acid Deriv (Indomethacin, Diclofenac, Ketorolac, Etodolac, Sulindac)
  - Oxicams (Piroxicam, Meloxicam - COX-2 preferential)
  - Anthranilic Acid Deriv (Mefenamic acid)
  - Pyrazolone Deriv (Phenylbutazone - historical, toxic)
- Selective COX-2 Inhibitors (Coxibs)
  - Celecoxib, Etoricoxib, Parecoxib (prodrug)
  - Rofecoxib, Valdecoxib (withdrawn)

### Therapeutic Uses
- Pain Relief (Mild to Moderate)
- Inflammatory Conditions (RA, OA, Ankylosing Spondylitis, Gout)
- Fever Reduction
- Dysmenorrhea
- Patent Ductus Arteriosus (Indomethacin, Ibuprofen)
- Prophylaxis of Colorectal Adenomas (Aspirin)
- Cardio- & Cerebrovascular Protection (Aspirin)

### Adverse Effects
- **Gastrointestinal** (Most Common)
  - Dyspepsia, Nausea, Vomiting
  - Gastric/Duodenal Ulcers
  - Bleeding, Perforation
  - Risk Factors: H/O ulcer, high dose, elderly, concurrent steroids/anticoagulants, H. pylori
  - Management: PPIs, Misoprostol
- **Renal**
  - Impaired Renal Blood Flow (especially in pre-existing renal disease, HF, dehydration, elderly)
  - Acute Kidney Injury (AKI)
  - Interstitial Nephritis
  - Papillary Necrosis
  - Fluid retention, Edema, Hypertension
- **Cardiovascular**
  - Increased risk of MI, Stroke, Thrombotic events (except Aspirin)
  - Associated with COX-2 inhibitors & ns-NSAIDs (Diclofenac high risk)
  - Worsening Heart Failure
- **Hematologic**
  - Platelet dysfunction (COX-1 inhibition - reversible except Aspirin)
  - Agranulocytosis (rare, e.g., Phenylbutazone)
  - Aplastic Anemia (rare)
- **Hepatic**
  - Elevated liver enzymes
  - Liver injury (rare, Diclofenac, Sulindac)
- **Hypersensitivity/Allergic**
  - Aspirin-exacerbated respiratory disease (AERD) / NSAID-induced asthma (Samter's Triad: Asthma, Nasal polyps, NSAID sensitivity)
  - Urticaria, Angioedema
  - Anaphylaxis (rare)
- **CNS**
  - Headache, Dizziness
  - Confusion, Aseptic Meningitis (rare, Ibuprofen, Naproxen)
  - Vertigo, Tinnitus (Salicylates)
- **Pregnancy**
  - Avoid in 3rd trimester (Premature closure of PDA, Oligohydramnios, PPHN)
  - Category C/D

### Contraindications
- Active Peptic Ulcer Disease, GI Bleeding
- Severe Renal Impairment
- Severe Hepatic Impairment
- Severe Heart Failure
- History of Angioedema/Bronchospasm to Aspirin/NSAIDs
- Concurrent use of multiple NSAIDs
- 3rd Trimester Pregnancy
- Post-CABG Surgery (Coxibs)

### Drug Interactions
- Warfarin/Anticoagulants: Increased bleeding risk
- Antiplatelets (Clopidogrel): Increased bleeding risk (except Aspirin)
- Corticosteroids: Increased GI ulcer risk
- SSRIs: Increased GI bleeding risk
- ACE inhibitors/ARBs/Diuretics: Attenuated anti-hypertensive effect, increased renal toxicity risk
- Methotrexate: Reduced clearance, increased toxicity
- Lithium: Reduced clearance, increased toxicity
- Digoxin: Reduced clearance, increased toxicity
- Beta-blockers: Attenuated anti-hypertensive effect

### Specific NSAIDs / High Yield Points
- **Aspirin:** Irreversible COX inhibition (platelets for life), Reye's Syndrome (children viral), Tinnitus (toxicity), Low dose (antiplatelet), High dose (anti-inflam), Samter's Triad.
- **Indomethacin:** Potent, high CNS side effects (headache), used for PDA closure, Gout.
- **Ketorolac:** Potent analgesic, limited anti-inflammatory, short-term use only (<5 days) due to GI/renal/bleeding risk.
- **Diclofenac:** Higher CV risk (ns-NSAID), higher hepatic risk.
- **Ibuprofen/Naproxen:** Relatively safer GI profile at lower doses (Naproxen longer half-life).
- **Piroxicam:** Long half-life, higher GI risk.
- **Meloxicam:** COX-2 preferential (at low doses), better GI profile than ns-NSAIDs, still some GI/renal risk.
- **Celecoxib:** Selective COX-2, lower GI risk vs ns-NSAIDs, higher CV risk (especially if pre-existing CVD), contra-indicated in Sulfa allergy.

### INICET Buzzwords
- Reye's Syndrome (Aspirin, Children, Viral infection)
- Samter's Triad (AERD, Aspirin, Asthma, Polyps)
- Papillary Necrosis (Renal side effect)
- Aseptic Meningitis (Ibuprofen, Naproxen)
- PDA Closure (Indomethacin, Ibuprofen)
- Short-term use only (<5 days) (Ketorolac)
- Irreversible Platelet Inhibition (Aspirin)
- Sulfa Allergy (Celecoxib)
- Post-CABG Contraindication (Coxibs)
- Misoprostol (GI protection)
- COX-1 vs COX-2 functions
- Thromboxane A2 (Platelet aggregation - COX-1)
- Prostaglandins (GI protection, Renal blood flow, Pain/Inflam - COX-1 & COX-2)
- Risk factors for NSAID toxicity


